Health News Archive

Enter a date to view that day's archives:

Showing 1-20 of 266 stories from the past year.

Avacen Medical announced that one of its medical devices received clearance by the U.S. Food and Drug Administration.


Targeson Inc., a developer of microsphere agents for functional and molecular ultrasound imaging, announced Monday that it's been selected to participate in the National Institutes of Health Regulatory Training Track of the Commercialization Assistance Program.

San Diego Chargers running back Ryan Mathews will be joined by some of his teammates next week in trading footballs for golf balls for a day at the Kaiser Permanente Second Annual Ryan Mathews Golf Tournament.

San Diego-based Halozyme Therapeutics Inc. (Nasdaq: HALO) announced that the U.S. Food and Drug Administration has approved new contract manufacturing facilities for the production of Hylenex recombinant (hyaluronidase human injection).

The first remote mobile communications device used for continuous glucose monitoring has received approval from the U.S. Food and Drug Administration.

Pathway Genomics Corp. has released an app that allows existing patients to view genetic results on mobile devices.


Two years ago, the area surrounded by biotech offices in Torrey Pines Science Park was a parking lot. Now, the lush green space is an oasis for employees, a nature classroom and a supplier for a campus restaurant.


About 2,000 bicyclists will ride this weekend in Southern California in support of for multiple sclerosis research, and are expected to raise about $2.2 million in donations.

Palomar Health is preparing to vaccinate more than 3,500 North County residents through its annual community flu shot program during the current flu season.


The next wave of electric vehicles could be powered by hydrogen fuel cell technology as several car manufacturers gear up to launch new models.

On the heels of a successful first year working to make National City more sustainable, San Diego State University’s Sage Project is seeking proposals from other San Diego County municipalities to partner with in the 2015-16 academic year.


The clinical-stage oncolytic immunotherapy company DNAtrix reported Tuesday that it has completed a $20 million Series B equity financing, led by new investor Morningside Ventures, based in Hong Kong.


California Bank & Trust has raised more than $35,000 through this year’s Together4Hope Walk, contributing to the total $100,000 raised for City of Hope.

Palomar Health is preparing to vaccinate more than 3,500 North County residents through its annual community flu shot program during the current flu season.

San Diego's Tabatha Parker has been appointed by Gov. Jerry Brown to the California Naturopathic Medicine Committee, the governor's office announced Monday.


San Diego-based Pfenex Inc. (NYSE: PFNX), a clinical-stage biotechnology company, initiated a multiproduct research program with PATH, a global health nonprofit organization, as part of an initiative to enhance production of vaccines.


The first patient was treated last week in the Phase 1 trial testing of NSI-566 human neural stem cells in the treatment of chronic spinal cord injury (cSCI) at the UC San Diego School of Medicine in collaboration with Maryland-based Neuralstem Inc. (NYSE: CUR).


San Diego’s homegrown industry is most often referred to as biotech, but that really does not capture the industry’s broad swath. In my view, what are generically labeled as biotech facilities are actuality life science facilities.


San Diego-based ResMed (NYSE:RMD) launched its S+ by ResMed product, a non-contact sleep system.

DNAtrix Inc.'s DNX-2401, a conditionally-replicative oncolytic adenovirus for malignant glioma, was granted Orphan Drug Status by the U.S. Food and Drug Administration. Glioma is the most common form of primary brain cancer.

Subscribe Today!